Life Science Compliance Update



Detecting the “Sham” in Speaker Programs

Written by , Posted in Transparency

Mark Labovitz, Ph.D., MBA and Jeffrey DiFrancesco, M.Sci., M.Eng., Principals, Attest Open-PaymentsTM

This paper explores whether the publically available Open Payments data can be employed, using the same factual basis as the Government in its March 2016 allegations against Novartis to detect potential “sham” speaker programs.


Topic tags:

Menu Title